FindTrial
Sign In

A study on pcod with insulin sensitivity using unani formulation

A COMPARATIVE STUDY OF MUR MAKKI(COMMIPHORA MYRRHA) AND METFORMIN ON IMPAIRED INSULIN SENSITIVITY IN MARZE AKYAS KHUSYTUR REHM (POLYCYSTIC OVARIAN SYNDROME- RANDOMIZED STANDARD CONTROL CLINICAL TRIAL - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085472
Enrollment
64
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N925- Other specified irregular menstruation

Interventions

Control Intervention1: 1.MUR MAKKI : 1.MUR MAKKI 250mg capsule twice daily for 90 days Control Intervention2: 2.METFORMIN: 2.METFORMIN 250mg capsule twice daily for 90 days

Sponsors

Govt nizamia tibbi college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PCOS diagnosed based on Rotterdam criteria age group 18-35 years fasting plasma glucose more then 110mgperdl fasting serum insulin more then 10 micro international unit per liter second hour OGTT more then 140mgperdl

Exclusion criteria

Exclusion criteria: Age more then 35 significant cardiovascular or pulmonary or hepatic renal dysfunction immune compromised state pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
improvement in insulin sensitivity by HOMA IR indexTimepoint: 12 weeks—

Secondary

MeasureTime frame
improvement in other parameter such as OGTT, DHEA-S Lipid profileTimepoint: 12 weeks—

Countries

India

Contacts

Public ContactDr A suhasini

Govt nizamia tibbi college and hospital

drasuhasini12@gmail.com9949586899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026